Promising new MND drug shown to reduce key disease markers
Promising data has led the Therapeutic Goods Administration to grant provisional approval of the drug, giving eligible patients in Australia faster access.
Original Source
Read the full article at 9news →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.